The record

LegislationLegislation· Jul 2026
HR 2821 Passed House — in Senate

Sponsored by Earl L. "Buddy" Carter (R)

FDA Modernization Act 3.0

Requires FDA to allow nonclinical testing methods instead of animal tests for new drug applications.

Tradeoff

Streamlines drug development by replacing animal testing requirements with alternative nonclinical methods. No direct federal spending or revenue impact.

What's in it

See official bill text

The House passed this by on July 20, 2026 — now in the Senate.

  1. House

    Introduced

    (Apr 10, 2025)

  2. House

    Committee on Energy and Commerce(Apr 10, 2025)

  3. House

    The Committee on Energy and Commerce voted to send it to the floor

    Reported 44 - 0(May 21, 2026)

    Committee report H. Rept. 119-706.

  4. House

    Passage of the bill

    Passed by (Jul 20, 2026)

    No individual votes were recorded.

  5. Senate

    Received from the House

    Received(Jul 21, 2026)